Ignite Creation Date:
2024-06-16 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06425991
Status:
RECRUITING
Last Update Posted:
2024-06-20
First Post:
2024-05-17
Brief Title:
A Study Comparing Pre- and Post-Change Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Sponsor:
Janssen Research Development LLC
Organization:
Janssen Research Development LLC
Organization Data
Organization:
Janssen Research Development LLC
Class:
INDUSTRY
Study ID:
64007957MMY1008
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Janssen Research Development LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None